New markers of neonatal neurology

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue SUPPL. 3, 2009, Pages 57-61

  Gazzolo, Diego ^a,b   Abella, Raul ^c   Marinoni, Emanuela ^d   Di Iorio, Romolo ^d   Li Volti, Giovanni ^e   Galvano, Fabio ^e   Frigiola, Alessandro ^c   Temporini, Francesca ^b   Moresco, Luca ^b   Colivicchi, Micaela ^b   Sabatini, Miriam ^b   Ricotti, Alberto ^b   Strozzi, Maria Chiara ^b   Crivelli, Sandro ^b   Risso, Francesco Maria ^a   Sannia, Andrea ^a   Florio, Pasquale ^f  

^a UNIVERSITY OF GENOA   (Italy)

^b C Arrigo Children's Hospital   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF SIENA   (Italy)

Author keywords

Activin A; Adrenomedullin; Brain damage; Newborn; Perinatal asphyxia; S100B

Indexed keywords

ACTIVIN A; ADRENOMEDULLIN; BIOLOGICAL MARKER; CALCIUM; NITRIC OXIDE; PROTEIN S100B; VASOACTIVE AGENT;

ARTIFICIAL VENTILATION; AUTOREGULATION; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CELL DEATH; CEREBRAL PALSY; CEREBROSPINAL FLUID; CLINICAL PRACTICE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL OXYGENATION; FETUS CIRCULATION; HIGH RISK INFANT; HUMAN; HYPOTENSION; HYPOXIA; ISCHEMIA; NEONATOLOGY; NERVOUS TISSUE; NEUROLOGY; PERINATAL ASPHYXIA; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

ACTIVINS; ADRENOMEDULLIN; ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; BRAIN INJURIES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 70449393953     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050903181468     Document Type: Review

References (41)

1. Visser GH. Why does perinatal morbidity increase. J Perinat Med 1994;22(Suppl 1):28-34.
2. Hagberg B, Hagberg G, Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-1990. Acta Paediatr 1996;85:954-960.
3. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatol 2000;5:3-16.
4. Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-1994. Acta Paediatr 2001;90:271-277.
5. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-167.
6. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-560.
7. Allen MA, Ferguson AV. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am J Physiol 1996;270(4 Part 2):R920-R925.
8. Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997;138:2615-2620. (Pubitemid 27215270)
9. Oehler MK, Norbury C, Hague S, Rees MC, Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: A possible promotion mechanism for tumour growth. Oncogene 2001;20:2937-2945.
10. Wang X, Yue TL, Barone FC, White RF, Clark RK, Willette RN, Sulpizio AC, Aiyar NV, Ruffolo RR Jr., Feuerstein GZ. et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci USA 1995;92:11480-11484.
11. Nagata D, Hirata Y, Suzuki E, Kakoki M, Hayakawa H, Goto A, Ishimitsu T, Minamino N, Ono Y, Kangawa K, et al. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int 1999;55:1259-1267.
12. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999;160:132-136. (Pubitemid 29326078)
13. Boldt T, Luukkainen P, Fyhrquist F, Pohjavuori M, Andersson S. Birth stress increases adrenomedullin in the newborn. Acta Paediatr 1998;87:93-94.
14. de Vroomen M, Takahashi Y, Gournay V, Roman C, Rudolph AM, Heymann MA. Adrenomedullin increases pulmonary blood flow in fetal sheep. Pediatr Res 1997;41(4 Part 1):493-497.
15. Yamashiro C, Hayashi K, Yanagihara T, Hata T. Plasma adrenomedullin levels in pregnancies with appropriate for gestational age and small for gestational age newborns. J Perinat Med 2001;29:513-518.
16. di Iorio R,Marinoni E, LituaniaM, Serra G, Letizia C, Cosmi EV, Gazzolo D. Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem 2004;37:1112-1116.
17. Rickmann M, Wolff JR. S100 protein expression in subpopulations of neurons of rat brain. Neuroscience 1995;67:977-991.
18. Yang Q, Hamberger A, Hyden H, Wang S, Stigbrand T, Haglid KG. S-100 beta has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method. Brain Res 1995;696:49-61.
19. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991;22:1254-1258.
20. Michetti F, Massaro A, Murazio M. The nervous systemspecific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 1979;11:171-175.
21. Michetti F, Massaro A, Russo G, Rigon G. The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. J Neurol Sci 1980;44):259-263.
22. Whitelaw A, Rosengren L, Blennow M. Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed 2001;84:F90-F91.
23. Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn newborns. Acta Paediatr 2001;90:1171-1175.
24. Sellman M, Ivert T, Ronquist G, Caesarini K, Persson L, Semb BK. Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid. Scand J Thorac Cardiovasc Surg 1992; 26:39-45.
25. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 1987;18:911-918.
26. Gazzolo D, Vinesi P, Bartocci M, Geloso MC, Bonacci W, Serra G, Haglid KG, Michetti F. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm newborns. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999;170:32-35.
27. Gazzolo D, di Iorio R, Marinoni E, Masetti P, Serra G, Giovannini L, Michetti F. S100B protein is increased in asphyxiated term newborns developing intraventricular hemorrhage. Crit Care Med 2002;30:1356-1360.
28. Nagdyman N, Komen W, Ko HK, Muller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001;49:502-506.
29. Gazzolo D, Masetti P, Meli M, Grutzfeld D, Michetti F. Elevated S100B protein as an early indicator of intracranial haemorrhage in newborns subjected to extracorporeal membrane oxygenation. Acta Paediatr 2002;91:218-221.
30. Golej J, Trittenwein G. Early detection of neurologic injury and issues of rehabilitation after pediatric cardiac extracorporeal membrane oxygenation. Artif Organs 1999;23:1020-1025.
31. Gazzolo D, Marinoni E, di Iorio R, Lituania M, Bruschettini PL, Michetti F. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res 2002;51: 215-219.
32. Gazzolo D, Marinoni E, di Iorio R, Lituania M, Marras M, Bruschettini M, Bruschettini P, Frulio R, Michetti F, Petraglia F, et al. High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. Clin Chem 2006;52:819-826.
33. Gazzolo D, Bruschettini M, Lituania M, Serra G, Gandullia E, Michetti F. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem 2001;47:1132-1133.
34. Gazzolo D, Bruschettini M, Lituania M, Serra G, Bonacci W, Michetti F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm newborns: correlation with the grade of hemorrhage. Clin Chem 2001; 47:1836-1838.
35. Gazzolo D, Marinoni E, di Iorio R, Bruschettini M, Kornacka M, Lituania M, Majewska U, Serra G, Michetti F. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term newborns. Arch Pediatr Adolesc Med 2003;157:1163-1168.
36. Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 2001;145:225-236.
37. Florio P, Abella RF, de la TT, Giamberti A, Luisi S, Butera G, Cazzaniga A, Frigiola A, Petraglia F, Gazzolo D. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin Chem 2007;53:982-985.
38. Florio P, Gazzolo D, Luisi S, Petraglia F. Activin A in brain injury. Adv Clin Chem 2007;43:117-130.
39. Florio P, Perrone S, Luisi S, Vezzosi P, Longini M, Marzocchi B, Petraglia F, Buonocore G. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516-1521.
40. Florio P, Luisi S, Bruschettini M, Grutzfeld D, Dobrzanska A, Bruschettini P, Petraglia F, Gazzolo D. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50:2386-2389.
41. Florio P, Luisi S, Moataza B, Torricelli M, Iman I, Hala M, Hanna A, Petraglia F, Gazzolo D. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem 2007;53:520-522.